Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-β's in epithelial ovarian tumors

Histology and Histopathology

Volumn 21, Issue 10-12, 2006, Pages 1055-1064

  Inan, Sevinc ^a   Vatansever, S ^a   Celik Ozenci, C ^b   Sanci, M ^c   Dicle, N ^d   Demir, R ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c Social Security Hospital   (Turkey)

^d NONE   (Turkey)

Author keywords

flt 1; KDR; Ovarian carcinoma; TGF ; VEGF

Indexed keywords

AVIDIN; BIOTIN; EOSIN; FORMALDEHYDE; HEMATOXYLIN; MONOCLONAL ANTIBODY; PARAFFIN; PEROXIDASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; FLT1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; LAPAROTOMY; METASTASIS POTENTIAL; MUCINOUS CARCINOMA; OVARY ADENOCARCINOMA; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; TISSUE FIXATION; TISSUE SECTION; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; VASCULAR ENDOTHELIUM; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); OVARY; OVARY TUMOR; PATHOLOGY;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; OVARY; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33746721000     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abu-Jawdeh G.M., Faix J.D., Niloff J., Tognazzi K., Manseau E., Dvorak H.F. and Brown L.F. (1996). Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab. Invest. 74, 1105-1115.
2. Abulafia O. and Sherer D.M. (2000). Angiogenesis of the ovary. Am. J. Obstet. Gynecol. 182, 240-246.
3. Bamberger E.S. and Perrett C.W. (2002). Angiogenesis in epithelian ovarian cancer. Mol. Pathol. 55, 348-359.
4. Bartlett J.M., Langdon S.P., Scott W.N., Love S.B., Miller E.P., Katsaros D., Smyth J.F. and Miller W.R. (1997). Transforming growth factor-beta isoform expression in human ovarian tumours. Eur. J. Cancer 33, 2397-2403.
5. Berek J.S., Adashi E.Y. and Hillard P.A. (1996). Novak's Gynecology 12th. Edition Williams & Wilkins. pp 1155-1217.
6. Boocock C.A., Charnock-Jones D.S., Sharkey A.M., McLaren J., Barker P.J., Wright K.A., Twentyman P.R. and Smith S.K. (1995). Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J. Natl. Cancer. Inst. 87, 506-516.
7. Brown M.R., Blanchette J.O. and Kohn E.C. (2000). Angiogenesis in ovarian cancer. Baillieres. Best Pract. Res. Clin. Obstet. Gynaecol. 14, 901-918.
8. Byrne A.T., Ross L., Holash J., Nakanishi M., Hu L., Hofmann J.I., Yancopoulos G.D. and Jaffe R.B. (2003). Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Clin. Cancer. Res. 9, 5721-5728.
9. Folkman J. (1986). How is the blood vessel growth regulated in normal and neoplastic tissue? Cancer. Res. 46, 467-473.
10. Folkman J. and Klagsbrun M. (1987). Angiogenic factors. Science 235, 442-447.
11. Gadducci A., Viacava P., Cosio S., Cecchetti D., Fanelli G., Fanucchi A., Teti G. and Genazzani A.R. (2003). Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma. Anticancer Res. 23, 3001-3008.
12. Gordinier M.E., Zhang H.Z, Patenia R., Levy L.B., Atkinson E.N., Nash M.A., Katz R.L., Platsoucas C.D. and Freedman R.S. (1999). Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma. Clin. Cancer Res. 5, 2498-2505.
13. Hazelton D.A. and Hamilton T.C. (1999). Vascular endothelial growth factor in ovarian cancer. Curr. Oncol. Rep. 1, 59-63.
14. Henriksen R., Gobl A., Wilander E., Oberg K., Miyazono K. and Funa K. (1995). Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab. Invest. 73, 213-220.
15. Ingman W.V. and Robertson S.A. (2002). Defining the actions of transforming growth factor beta in reproduction. Bioessays 24, 904-914.
16. Nakanishi Y., Kodama J., Yoshinouchi M., Tokumo K., Kamimura S., Okuda H. and Kudo T. (1997). The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer. Int. J. Gynecol. Pathol. 16, 256-262.
17. Neufeld G., Cohen T., Gengrinovitch S. and Poltorak Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
18. Nilsson E., Doraiswamy V., Parrott J.A. and Skinner M.K. (2001). Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian, cancer. Mol. Cell. Endocrinol. 182, 145-155.
19. Orre M. and Rogers P.A. (1999). VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary. Int. J. Cancer 84, 101-108.
20. Patan S. (2004). Vasculogenesis and angiogenesis. Cancer. Treat. Res. 117, 3-32.
21. Pepper M.S. (1997). Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8, 21-43.
22. Rodriguez G.C., Haisley C., Hurteau J., Moser T.L., Whitaker R., Bast R.C. Jr. and Stack M.S. (2001). Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol. Oncol. 80, 245-253.
23. Sonoda T., Kobayashi H., Kaku T., Hirakawa T. and Nakano H. (2003). Expression of angiogenesis factors in monolayer culture, multicellular spheroid and in vivo transplanted tumor by human ovarian cancer cell lines. Cancer 10, 229-237.
24. Sowter H.M., Corps A.N., Evans A.L., Clark D.E., Charnock-Jones D.S. and Smith S.K. (1997). Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab. Invest. 77, 607-614.
25. Tanir H.M., Ozalp S., Yalcin O.T., Colak O. and Akcay A. (2003). Senses preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses. T. Eur. J. Gynaecol. Oncol. 24, 271-274.
26. Wong C., Wellman T.L. and Lounsbury K.M. (2003). VEGF and HIF-1 alpha expressions are increased in advanced stages of epithelial ovarian cancer. Gynecol. Oncol. 91, 513-517.